A team of researchers has observed that blood test samples might help in detecting the risk of breast cancer relapse in the patients.
By making use of the data obtained from the immune response of an individual, a team of researchers has observed that a blood test might help in accurately predicting the risk of the recurrence of breast cancer in patients.
Even after major advancements in the field of breast cancer research & treatment, this form of cancer still remains as the leading type of cancer in women all around the world. Moreover, most of the breast cancer survivors have the constant worry about their cancer relapsing after a specific period. The researchers are thus continually studying the discern patterns of how breast cancer recurs after a specific period in some cases.
Using a Blood Test to Predict the Recurrence of Breast Cancer
In a recent study, a team of researchers aims at analyzing the anti-tumor inflammatory response of the body for devising a specialized blood test that can soon help in predicting the chances of an individual to experience the recurrence of breast cancer.
Dr. Peter P. Lee –Chairman at the Department of Immuno-Oncology, City of Hope Comprehensive Cancer Center, Duarte (CA), is the senior author of the study. The reports of the study were published in the leading journal named “Nature Immunology.”
Blood Test Predicting Cancer Relapse Risk Within 3-5 Years
In the research paper, Dr. Lee along with his colleagues, states that the balance between the anti-inflammatory signaling of the body and pro-inflammatory signaling of the immune system with respect to cytokines can help in determining the anti-tumor immune reaction of an individual.
For the given study, the team of researchers recruited as many as 40 survivors of breast cancer by clinically following their condition for around 4 years. The researchers also utilized another group of 38 cancer survivors towards replicating their findings from the previous survivors’ group.
The researchers observed that the signaling response present in the T-reg cells got altered for 2 anti-inflammatory and pro-inflammatory cytokines in some of the survivors. The respective signaling responses tended to correlate the current state of the immune system of the participants delivering accurate predictions of the recurrence of breast cancer within 3-5 years. This finding can turn out revolutionary in the field of breast cancer research and treatment options in the future.